Hemogenyx Pharmaceuticals Plc (LON:HEMO)
London flag London · Delayed Price · Currency is GBP · Price in GBX
714.10
-65.40 (-8.39%)
Jun 16, 2026, 10:29 AM GMT

Hemogenyx Pharmaceuticals Market Cap

Hemogenyx Pharmaceuticals has a market cap or net worth of 53.01 million as of June 16, 2026. Its market cap has increased by 598.33% in one year.

Market Cap
53.01M
Enterprise Value
53.37M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
714.10

Market Cap Chart

Since October 6, 2017, Hemogenyx Pharmaceuticals's market cap has increased from 10.68M to 53.01M, an increase of 396.25%. That is a compound annual growth rate of 20.25%.

History

DateMarket Cap% Change
Jun 12, 202656.13M62.44%
Dec 31, 202534.56M143.47%
Dec 31, 202414.19M-47.51%
Dec 29, 202327.04M108.28%
Dec 30, 202212.98M-29.33%
Dec 31, 202118.37M-56.10%
Dec 31, 2020 Pro Pro
Dec 31, 2019 Pro Pro
Dec 31, 2018 Pro Pro
Dec 29, 2017 Pro Pro
Oct 6, 2017 Pro Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding
Full Definition

Related Stocks

CompanyMarket Cap
Faron Pharmaceuticals Oy91.30M
Bioventix84.90M
4basebio81.26M
Ondine Biomedical67.54M
hVIVO58.05M
Poolbeg Pharma54.29M
Sareum Holdings31.87M
ImmuPharma30.01M
Market Cap Rankings